Table 1 Summary of baseline characteristics of included studies in meta-analysis
Authors (Year) | Trial name | Comparison | Number of patients | Age (years) | Male (%) | Clinical symptom | Hypertension | Prior MI | Prior PCI | Prior CABG | Prior stroke |
|---|---|---|---|---|---|---|---|---|---|---|---|
IABP-SHOCK II | IABP | 301 | 70 (58, 78)a | 67.1 | MI complicated by CS | 213/296 (72.0 %) | 71/300 (23.7 %) | 63/299 (21.1 %) | 20/300 (6.7 %) | 24/300 (8.0 %) | |
without IABP | 299 | 69 (58, 76)a | 70.6 | 199/299 (66.6 %) | 61/299 (20.4 %) | 52/299 (17.4)% | 12/299 (4.0 %) | 20/299 (6.7 %) | |||
Gu (2011) [24] | -- | IABP | 51 | 67.4 (9.6) | 56.9 | Acute STEMI or non-STEMI without CS | 35 (68.6 %) | 2 (3.9 %) | NR | NR | NR |
without IABP | 55 | 66.6 (8.0) | 65.5 | 33 (60.0 %) | 3 (5.5 %) | NR | NR | NR | |||
Patel (2011) [23] | CRISP AMI | IABP | 161 | 56.1 (48.3, 64.3)a | 82.0 | Acute STEMI without CS | 39 (24.2 %) | NR | 3 (1.9 %) | NR | 0 |
without IABP | 176 | 57.7 (48.6, 66.4)a | 81.8 | 60 (34.1 %) | NR | 2 (1.1 %) | NR | 1 (0.6 %) | |||
BCIS-1 | IABP | 151 | 71 (9) | 81 | High risk PCI without CS | 95 (63 %) | 113 (75 %) | 17 (11 %) | 25 (17 %) | 12 (8 %) | |
without IABP | 150 | 71 (10) | 78 | 91 (61) | 108 (73 %) | 14 (9 %) | 20 (13 %) | 11 (7 %) | |||
Prondzinsky (2010) [28] | IABP SHOCK | IABP | 19 | 62.1 (38, 82)b | 74 | Acute MI complicated by CS | 8 (42.1 %) | 4 (21.1 %) | NR | NR | NR |
without IABP | 21 | 66.1 (49, 82)b | 81 | 10 (47.6 %) | 5 (23.8 %) | NR | NR | NR | |||
van't Hof (1999) [29] | -- | IABP | 118 | 59 (10) | 84 | High risk PCI without CS | NR | 17 (14 %) | NR | 3 (3 %) | NR |
without IABP | 120 | 56 (11) | 84 | NR | 16 (13 %) | NR | 7 (6 %) | NR | |||
Stone (1997) [25] | PAMI-II TRIAL | IABP | 211 | 64.7 (11.9) | 74.9 | High risk MI without CS | 116 (54.8 %) | 45 (21.4 %) | NR | 16 (7.5 %) | NR |
without IABP | 226 | 63.7 (13.0) | 75.2 | 126 (55.7 %) | 49 (21.7 %) | NR | 13 (5.9 %) | NR |